The Georgia Cancer Center seamlessly brings together high-quality clinical care with translational research in its role as the cancer center for the state’s academic medical center at Augusta University.
The center is on a path to achieve National Cancer Institute designation through NCI’s Cancer Center Support Grant program by 2020—becoming only the second institution in the state to do so.
By definition, an NCI-designated cancer center is a leader in nationally recognized cancer research, which includes clinical trials.
Georgia Cancer Center has a long history of bringing clinical trials, including therapies developed in its own labs, to both adults and children with all types of cancer. Its relationship with the NCI’s community oncology research programs began in 1994 with a predecessor, the minority-based community clinical oncology program, or MBCCOP.
Today, Georgia Cancer Center continues to lead the state’s only minority-based research program through the NCI’S NCORP.
The center offers comprehensive care for children and adults using a patients-first model, which emphasizes the best treatments available along with a wide range of supportive services, including integrative medicine. It also features: